In continuation of the outcome of Board Meeting held on 10-Jan-2025, Fund Raising Committee of the Board at its meeting held on 30-Jan-2025 approved, inter alia, revision in list of allottees and change in Notice of EGM and issue of Corrigendum to the Notice of Extraordinary General Meeting scheduled on Tuesday, 04-Feb-2025.
Announcement under Regulation 30 (LODR)-Issue of Securities
Filed with BSE · · 3 pages · English
Release
Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Sudarshan Pharma Industries Ltd Press Release Jan 16 2025
- Announcement under Regulation 30 (LODR)-Acquisition
- Premises Taken On Rent For Setting Up New Research & Development Formulation Centre In Dehradun, Uttarakhand, India - Clarification
- Sudarshan Pharma Industries Ltd Press Release Jan 14 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Later from Sudarshan Pharma Industries
- Corrigendum To Notice Of Extra-Ordinary General Meeting Dated 10-Jan-2025
- Sudarshan Pharma Industries Ltd Press Release Jan 31 2025
- Proceedings Of Extraordinary General Meeting
- Sudarshan Pharma Industries Ltd Press Release Feb 04 2025
- Shareholder Meeting / Postal Ballot-Outcome of EGM
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries